8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...

8/7/2025Innovation through Talent: How Leadership Is Evolving in China's Life ...

8/6/2025Novartis Heart Drug A China Case Study: How Drug Exclusivity Dies by a...

8/6/2025Big Pharma Provides Lifeline to Chinese Companies Struggling To Surviv...

8/6/2025CDE Seeks Public Comments on Revised Technical Guidelines for Recombin...

8/6/2025CDE Solicits Comments on Guidelines for Developing Appropriate Drug Pa...

8/6/2025Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...

8/6/2025Chinese Private Biopharma Sees Surge in July Financing, Highest Since ...

8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial

8/6/2025China's CGT Boom: NMPA's CDE and Tsinghua Team Publish Eight-Year Revi...

8/6/2025China Launches 11th National VBP Round with New Flexibility for Hospit...

8/6/2025CDE Releases Updated Roster of External Drug Review Experts

8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery

8/6/2025Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...

8/6/2025XTalPi Signs US$6 Billion Global Drug Discovery Deal with DoveTree

8/6/2025China Urges Price Discipline as Drugmakers Flood Latest VBP Tender

8/5/2025Sanofi Withdraws Praluent from China Amid Strategic Shift

8/5/2025China Issues 2025 Code of Ethics for Medical Professionals

8/5/2025China Seeks Public Feedback on New Internet Drug and Device Informatio...

8/5/2025Sciwind in Talks to License Weight-Loss Drug to U.S. Partner, Eyes Glo...

8/5/2025TenNor Files for Hong Kong IPO to Fund Breakthrough Antibacterial Prog...

8/5/2025China Biopharma Licensing Deals Soar in July, Driven by $500M Hengrui-...

8/5/2025Sanofi Attributes Praluent's China Exit to Global Supply Strain and St...

8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...

8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...

8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD

8/5/2025Metis Raises CNY 400M in Series D to Fuel AI-Driven Drug Development

8/5/2025CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...

8/5/2025EMBIOS Secures Pre-A Funding to Advance First-in-Class Autoimmune Ther...

8/5/2025Zenitar Raises ~CNY 400M to Accelerate AI-Driven Drug Discovery and O...

Page:8/789 Total number of articles:23668: [First][<<] [6] [7] [8] [9] [10] [>>] [End]